Document is current
Any future updates will be listed below
-
Authors
Sonal, Swati https://orcid.org/0000-0002-4038-2993
Deshpande, Vikram
Ting, David T.
Cusack, James C.
Parikh, Aparna R.
Neyaz, Azfar
Pankaj, Amaya
Taylor, Martin S.
Dinaux, Anne M.
Leijssen, Lieve G. J.
Boudreau, Chloe
Locascio, Joseph J.
Kunitake, Hiroko
Goldstone, Robert N.
Bordeianou, Liliana G.
Cauley, Christy E.
Ricciardi, Rocco
Berger, David L. https://orcid.org/0000-0002-0328-4235
- License Information
-
More Information
Article History
First Online: 25 August 2022
Disclosure
: D.T.T. has received consulting fees from ROME Therapeutics, Tekla Capital, Ikena Oncology, Foundation Medicine, Inc., NanoString Technologies, EMD Millipore Sigma, and Pfizer that are not related to this work. D.T.T. is a founder and has equity in ROME Therapeutics, PanTher Therapeutics and TellBio, Inc., which is not related to this work. D.T.T. receives research support from ACD-Biotechne, PureTech Health LLC, and Ribon Therapeutics, which was not used in this work. D.T.T.’s interests were reviewed and are managed by Massachusetts General Hospital and Mass General Brigham in accordance with their conflict of interest policies.
